Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
scientific article
Author/s
author: Grace Naswa Makokha, Daiki Miki, Kazuaki Chayama, Michio Imamura, Hiroshi Aikata, Masataka Tsuge, Tomokazu Kawaoka, Yoshiiku Kawakami, Akira Hiramatsu, Hidenori Ochi, C Nelson Hayes, Takashi Nakahara, Kei Morio, Hatsue Fujino, Atsushi Ono, Hiromi Kan, Tomoki Kobayashi, Yuko Nagaoki
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.